Fig. 2
![Fig. 2](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12879-018-3593-8/MediaObjects/12879_2018_3593_Fig2_HTML.png)
Levels of soluble leukocyte activation markers at admission and follow-up. Plasma/serum levels of MPO (a), sCD25 (b), sCD14 (c) and sCD163 (d) in patients with HIV infection without malaria (n = 49), patients with falciparum malaria without (n = 6) and with HIV infection (n = 22) at admission (before) and 48 h thereafter (after). Data are given as median and 25-75th percentiles. **p < 0.01 and ***p < 0.001 versus levels at admission. The horizontal grey shaded area represent levels 25-75th percentiles in age- and sex-matched healthy controls (n = 52). In all three groups of patients, all parameters were significantly raised compared with levels in controls both at admission and during follow-up (p < 0.001 for all comparisons)